Search Results - "Busweiler, L. A. D."

Textbook outcome as a composite measure in oesophagogastric cancer surgery by Busweiler, L. A. D., Schouwenburg, M. G., van Berge Henegouwen, M. I., Kolfschoten, N. E., de Jong, P. C., Rozema, T., Wijnhoven, B. P. L., van Hillegersberg, R., Wouters, M. W. J. M., van Sandick, J. W., Bosscha, K., Cats, A., Dikken, J. L., van Grieken, N. C. T., Hartgrink, H. H., Lemmens, V. E. P. P., Nieuwenhuijzen, G. A. P., Plukker, J. T., Rosman, C., Siersema, P. D., Tetteroo, G., Veldhuis, P. M. J. F., Voncken, F. E. M.

“…Background Quality assurance is acknowledged as a crucial factor in the assessment of oncological surgical care. The aim of this study was to develop a…”
Get full text

Early outcomes from the Dutch Upper Gastrointestinal Cancer Audit by Busweiler, L. A. D., Wijnhoven, B. P. L., van Berge Henegouwen, M. I., Henneman, D., van Grieken, N. C. T., Wouters, M. W. J. M., van Hillegersberg, R., van Sandick, J. W.

“…Background In 2011, the Dutch Upper Gastrointestinal Cancer Audit (DUCA) group began nationwide registration of all patients undergoing surgery with the…”
Get full text

Hospital variation and the impact of postoperative complications on the use of perioperative chemo(radio)therapy in resectable gastric cancer. Results from the Dutch Upper GI Cancer Audit by Schouwenburg, M.G., Busweiler, L.A.D., Beck, N., Henneman, D., Amodio, S., van Berge Henegouwen, M.I., Cats, A., van Hillegersberg, R., van Sandick, J.W., Wijnhoven, B.P.L., Wouters, M.W.J., Nieuwenhuijzen, G.A.P.

“…Dutch national guidelines on the diagnosis and treatment of gastric cancer recommend the use of perioperative chemotherapy in patients with resectable gastric…”
Get full text

International benchmarking in oesophageal and gastric cancer surgery by Busweiler, L A D, Jeremiasen, M, Wijnhoven, B P L, Lindblad, M, Lundell, L, van de Velde, C J H, Tollenaar, R A E M, Wouters, M W J M, van Sandick, J W, Johansson, J, Dikken, J L

“…Benchmarking on an international level might lead to improved outcomes at a national level. The aim of this study was to compare treatment and surgical outcome…”
Get full text

Factors contributing to variation in the use of multimodality treatment in patients with gastric cancer: A Dutch population based study by Beck, N., Busweiler, L.A.D., Schouwenburg, M.G., Fiocco, M., Cats, A., Voncken, F.E.M., Wijnhoven, B.P.L., van Berge Henegouwen, M.I., Wouters, M.W.J.M., van Sandick, J.W., Bosscha, K., Dikken, J.L., van Duijvendijk, P., van Grieken, N.C.T., Gisbertz, S.S., Hartgrink, H.H., Hartemink, K.J., Van Hillegersberg, R., Hulsewé, K., Kouwenhoven, E., Lemmens, V.E.P.P., Nieuwenhuijzen, G.A.P., Ooijen, B., Plukker, J.T., Rosman, C., Scheepers, J., Siersema, P.D., de Steur, W.O., Tetteroo, G., Veldhuis, P.M.J.F.

“…Substantial variation in the use of (neo) adjuvant treatment in patients with gastric cancer exists. The aim of this study was to identify underlying…”
Get full text